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ABSTRACT
Objective: Frustration continues to be directed at
delays in gaining approvals for undertaking health
research in the UK. We aimed to evaluate the impact of
an ethics officer intervention on rates of favourable
opinions (approval) and provisional opinions (requiring
revision and resubmission) and on the time taken to
reach a final opinion by research ethics committees
(RECs), to characterise how the role operated in
practice, and to investigate applicants’ views.
Design: Mixed-method study involving (i) a 2-group,
non-randomised before-and-after intervention study of
RECs assigned an ethics officer and a matched
comparator group; (ii) a process evaluation involving a
survey of applicants and documentary analysis.
Participants: 6 RECs and 3 associated ethics officers;
18 comparator RECs; REC applicants.
Results: Rates of provisional and favourable opinions
between ethics officer and comparator RECs did not show
a statistically significant effect of the intervention (logistic
regression, p=0.26 for favourable opinions and p=0.31 for
provisional opinions). Mean time to reach a decision
showed a non-significant reduction (ANOVA, p=0.22) from
33.3 to 32.0 days in the ethics officer RECs compared
with the comparator RECs (32.6 to 32.9 days). The survey
(30% response rate) indicated applicant satisfaction and
also suggested that ethics officer support might be more
useful before submission. Ethics officers were successful
in identifying many issues with applications, but the
intervention did not function exactly as designed: in 31%
of applicants, no contact between the applicants and the
ethics officer took place before REC review.
Limitations: This study was a non-randomised
comparison cohort study. Some data were missing.
Conclusions: An ethics officer intervention, as
designed and implemented in this study, did not
increase the proportion of applications to RECs that
were approved on first review and did not reduce the
time to a committee decision.
BACKGROUND
The importance and public beneﬁts of health
research have been repeatedly emphasised;
research is now recognised as the corner-
stone of evidence-based healthcare and crit-
ical for health system strengthening
worldwide.1–5 However, the commitment to
research is balanced against a number of
other goals, including those relating to the
control of risks and the safeguarding of
research participants.6 How health research
can best be governed and regulated remains
an elusive question.7 Globally, reports of
resentment and criticism continue to be
directed at many parts of the system of ethical
review and governance approvals.8–10 11–13
How ethics and governance processes might
be improved has remained, perhaps ironic-
ally, rarely formally evaluated.14 While the
apparent arbitrary nature of decision-making
is a frequent source of problem,15 16 one
potentially more easily tractable target for
Strengths and limitations of this study
▪ This study is one of the few controlled evalua-
tions of a quality improvement intervention in
research ethics review.
▪ The study provides evidence that provision of an
ethics officer role, at least as deployed in this
project, does not shorten time to final decision
by research ethics committees nor increase the
proportion of applications that got a favourable
opinion first time.
▪ Use of a process evaluation involving quantitative
and qualitative methods enabled insights into the
null effect of the intervention: it did not operate
precisely as intended, and changes in culture
and behaviour on the part of both research
ethics committees and applicants are likely to be
needed to secure change.
▪ The study was limited by missing data for the
controlled evaluation and the process evaluation.
▪ The study would have been improved by further
qualitative work, including interviews with partici-
pants and ethnography of meetings.
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improvement is the delay associated with obtaining
approvals for conducting research.17 In this article, we
report a controlled study of an intervention aimed at
reducing delays associated with research ethics commit-
tee (REC) approval.
Our study was based in the UK, where the research
ethics system (ﬁgure 1) established under the Research
Governance Framework6 requires that REC opinions be
rendered within 60 days of submission. This target is
consistently met.18 The Health Research Authority
(HRA), which administers the system of RECs, has add-
itionally set a stretch target that 95% of applications to
full REC meetings have a ﬁnal decision within 40 days.
This target was met for 91% of applications in
December 2014.18 However, these times to approval do
not count periods while the ‘clock’ is stopped while
applicants undertake any revisions that are required by
RECs, meaning that in practice applicants may experi-
ence longer actual times to approval than those mea-
sured by formal clock times.
The length of time an application is in the process is
strongly linked to the decision made when it is reviewed
for the ﬁrst time by an REC. At this ﬁrst review, RECs
have a choice of four decisions, known formally as opi-
nions, which are recorded on an HRA electronic man-
agement information system. Unfavourable opinions,
Figure 1 Overview of research
ethics review process. CBS,
Central Booking Service; IRAS,
Integrated Research Application
System; NHS, National Health
Service; REC, research ethics
committee; R&D, research and
development; SSA, site-specific
assessment; SSI, site-specific
information.
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which remain rare (5% of applications to full commit-
tees, January–December 2015), result in applications
being rejected altogether. Favourable opinions, which may
be issued with a requirement for minor amendments
known as ‘additional conditions’ (19% of 2015 applica-
tions) or without conditions (5%), allow applicants to
proceed with their study without delay, since such appli-
cations do not need to be re-reviewed by the REC. A pro-
visional opinion (71% of 2015 applications to full REC
meetings), on the other hand, means that applicants
must revise and resubmit their application and have it
reviewed again by the REC, usually through subcommit-
tee or chair’s action. Such an opinion stops the clock on
the 60-day limit while the applicants undertake revisions;
the clock does not start again until they resubmit, poten-
tially resulting in considerable time elapsing before a
favourable opinion is obtained. Provisional opinions
therefore have the potential to introduce delay, adminis-
trative burden and cost. They have remained the most
common outcome of an application for REC approval.
Yet, virtually all (99.9% in 2015) applications with a provi-
sional opinion are given a favourable opinion once the
application has been revised, suggesting that the issues
detected at ﬁrst review are almost always remediable.
Many of the frustrations associated with ethics review,
by applicants and RECs, might be reduced if it were pos-
sible to get applications ‘right ﬁrst time’ resulting in a
favourable opinion. The issues that are likely to be
raised by RECs at review are now well understood: they
include ethical and procedural issues.19–22 At least some
of the issues that contribute to provisional and unfavour-
able opinions are, in principle, preventable by better
preparation on the part of applicants.19–21 One study,
for example, found that 87% of applications not
approved at ﬁrst review had issues that included proced-
ural violations, missing information, slip-ups such as
errors in grammar and spelling, and discrepancies
between different parts of the application.20
We hypothesised that an intervention to address these
problems, involving more upfront effort invested in iden-
tifying issues with applications, could result in a higher
rate of favourable opinions at ﬁrst review and a conse-
quent reduction in provisional opinions. We report a
mixed-method, controlled evaluation of an ethics ofﬁcer
intervention designed to identify issues early, discuss
them with applicants and communicate them to RECs.
We aimed to assess whether assigning an ethics ofﬁcer to
an REC could increase the rate of favourable opinions
and reduce the rate of provisional opinions and the time
taken by the REC to reach a ﬁnal opinion, as well as to
characterise how the ethics ofﬁcer role operated in prac-
tice and to investigate applicants’ views of the role.
METHODS
A two-group, non-randomised, before-and-after interven-
tion study was designed to compare the outcomes of
applications submitted to RECs to which an ethics ofﬁcer
was assigned (the intervention group, referred to as
‘ethics ofﬁcer RECs’) with matched control RECs without
ethics ofﬁcers (referred to as ‘comparator RECs’),
together with a qualitative process evaluation. The inter-
vention study was led by the HRA, guided by an advisory
group at the design stage. The process evaluation was
conducted and funded separately (see statements).
The project was deemed to be service evaluation and
thus did not require review by an REC. All applicants to
RECs in the ethics ofﬁcer group were advised of the
study and given the opportunity to opt-out of having
their application considered by the ethics ofﬁcer.
The ethics officer intervention
An ethics ofﬁcer was chosen as an intervention as other
possible tactics to improve timeliness of review, including
encouragement to RECs to use the ‘favourable with con-
ditions’ option where appropriate, training for REC
members and applicants and use of an electronic appli-
cation handling system, had already been implemented.
It was considered that provision of additional advice and
support to applicants and committees might be a useful
innovation. Accordingly, the ethics ofﬁcer’s role was to:
▸ Assess each application before the REC review meeting
to identify any issues with the application that might
prevent the REC from issuing a favourable opinion.
Ethics ofﬁcers were asked to use a brief eight-section
review form (see box 1) to record all issues in applica-
tions at pre-review and during the meeting.
▸ Contact applicants to discuss the issues they had iden-
tiﬁed, including those that, in the opinion of the
ethics ofﬁcer, might result in changes being required
by the REC. The ethics ofﬁcer could discuss what
changes might be made with a view to ensuring that
the applicant would be better prepared to answer
queries from the REC. The ethics ofﬁcer could agree
on clariﬁcations and appropriate responses with
applicants in advance of the REC meeting. Ethics
Box 1 Sections on ethics officer review form
1. Issues which may cause an application to not receive a favour-
able opinion (to be completed by the ethics officer in advance
of the research ethics committee (REC) meeting and updated
with any comments subsequent to the meeting).
2. Guidance or legal requirements for the REC to consider.
3. Prior assessment of application, including necessity for REC
review, suitability of insurance arrangements, appropriate
completion of study type on application, etc.
4. Advice received by the researcher.
5. Review of the participant information sheet and consent form
(eg, to identify areas where they were inconsistent, incorrect
or required additions and clarifications).
6. Attendance by the researcher (with ethics officers advised not
to inform researchers that attendance was not required).
7. Time spent on application by the ethics officer.
8. Any other comments.
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ofﬁcers were additionally requested to discuss
whether applicants should attend in person or by
phone. Ethics ofﬁcers were asked to record the out-
comes of these discussions with applicants on the
review form.
▸ Report to the REC, on request, any issues noted on
the pre-review form that the REC had not itself
identiﬁed.
RECs were asked to conduct their review as normal.
Neither applicants nor ethics ofﬁcers were authorised to
make any changes to the application or to submit
additional documentation before the application was
considered by the REC. This was because the systems in
place validated applications on submission an electronic
application handling system; applications could not then
be amended until they had been reviewed by an REC
unless they were formally withdrawn, resubmitted and
validated again, thus potentially jeopardising dates
booked for REC review when the application was initially
submitted and assigned to a committee for a booked
slot. It was considered that implementing a systems
change to allow such resubmissions was outside the
scope of this project. Ethics ofﬁcers could, however,
present a list of amendments (proposed solutions to
problems) that they had agreed with the applicants
before the applicant joined the meeting (or, if the appli-
cant was not present, before the REC made its decision).
Applicants could also refer to these agreed amendments
during their meeting with the REC.
The ethics ofﬁcer intervention sought to (i) decrease
the proportion of provisional opinions (requiring resub-
mission and review) and (ii) increase the proportion of
favourable opinions with or without additional conditions,
which together we call ‘favourable opinions’.
The theory of change23 was that the ethics ofﬁcer
would reassure REC members that the revisions needed
to comply with their expectations were understood by
the applicants and would be implemented correctly, so
that, rather than issuing a provisional opinion that
would stop the clock and result in a resubmission and
re-review, the REC would feel more conﬁdent about
issuing a favourable opinion with additional conditions,
and avoid unnecessary delay and the burden of the
further approval route for both parties.
REC selection and matching
In line with the HRA’s wish to reduce the proportion of
provisional opinions, the number of ethics ofﬁcer and
comparator RECs was chosen to detect, with 90% power
and 5% signiﬁcance level, a reduction in the proportion
of provisional opinions from 70% to 50% in the ethics
ofﬁcer RECs.
Six RECs in England were chosen to have an ethics
ofﬁcer assigned to them for the 2013 calendar year, and
thus formed the intervention group. These six RECs
were located in centres which were considered ‘stable’,
in that they were not then undergoing organisational
change and had meeting dates that were compatible
with the ethics ofﬁcers’ availabilities. Three ethics
ofﬁcers were appointed through an application and
interview process following advertisement to all REC
members and members of the National Research Ethics
Advisors’ Panel, with the aim of identifying individuals
with appropriate expertise and experience. Each ethics
ofﬁcer was assigned a case load of two RECs.
The period January–April 2013 was used as a familiar-
isation period, and then the intervention was implemen-
ted during meetings held from May to November 2013
(the ‘intervention’ period). The same period a year
earlier, including meetings held from May to November
2012, was used to provide preintervention baseline data.
We sought to match three comparator RECs to each
of the six ethics ofﬁcer RECs, so that 18 matched con-
trols would be available. A panel of candidate RECs in
England and Wales was created, with the comparator
RECs matched in the ﬁrst instance based on whether
they were legally ‘recognised’ for review of Clinical Trials
of Investigational Medicinal Products (CTIMPs). Of the
six ethics ofﬁcer RECs, one was recognised for review of
CTIMPs including phase I trials in healthy volunteers;
four were recognised for review of CTIMPs other than
for healthy volunteers; and one was not recognised to
review CTIMPs. Thus, ﬁve of the six ethics ofﬁcer RECs
were recognised to review CTIMPs (although each was
‘ﬂagged’ for other types of review, such as for applica-
tions involving human tissue, qualitative methods, chil-
dren, etc, which was not taken into account) and were
matched with equivalent comparator RECs.
The next step in the matching process was to try to
allow for the type of application the RECs were actually
reviewing rather than what they were ﬂagged to review.
Each application to an REC is categorised as interven-
tional or non-interventional, where ‘interventional’ is
deﬁned as a study where any intervention in care is evalu-
ated, regardless of whether the intervention is medicinal.
For each of the six ethics ofﬁcer RECs, the three chosen
comparators were those that had the same CTIMP
recognition and achieved the closest match in the per-
centage of interventional studies reviewed from May to
November 2012. Thus, there was no random element in
the selection of comparators. It had been intended to
match further by the percentage of provisional opinions
issued by the RECs in the baseline ‘before’ period
May–November 2012. However, this proved too difﬁcult,
mainly because one of the ethics ofﬁcer RECs had a
notably low provisional opinion rate (25%) during 2012,
for which no match could be found.
Quantitative data collection, outcomes and analysis
The primary outcomes were as follows:
▸ The number of provisional opinions at ﬁrst review,
expressed as a percentage of all applications reviewed.
▸ The number of favourable opinions (deﬁned as
favourable opinions at ﬁrst review with or without
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additional conditions), expressed as a percentage of
all applications reviewed.
The secondary outcome was the ‘clock time’ (the
number of days taken by the REC from receipt of a valid
application to issuing a ﬁnal opinion, excluding time
taken by the applicant to reply fully to queries).
To obtain relevant data, the HRA administrative data-
base (Research Ethics Database (RED), now replaced by
the HRA Assessment Review Portal (HARP)) that
records all opinions made about applications and holds
copies of the correspondence between applicants and
REC was queried. The initial opinion on each applica-
tion rendered by all RECs in the study over the baseline
period May–November 2012 and the intervention
period May–November 2013 was identiﬁed, and data on
time to ﬁnal opinion were extracted.
Statistical analysis was carried out using logistic regres-
sion of the two binary outcomes separately (favourable
and provisional opinions), and by univariate analysis of
variance for clock times. SPSS software (V.21) was used.
The logistic regressions treated each application to an
REC as the unit of analysis. For the ﬁrst of these, an
approval (favourable or favourable with conditions) at
ﬁrst review was taken as the outcome of interest and was
compared with all other outcomes. For the second
regression, a provisional opinion at ﬁrst review was com-
pared with all other outcomes.
Explanatory variables entered into the regressions
were as follows: year (2012 or 2013), ethics ofﬁcer versus
comparator REC and the interaction of these two terms.
The ﬁrst term was to uncover any trend in overall out-
comes between 2012 and 2013. The second was to allow
for baseline differences between ethics ofﬁcer and com-
parator RECs, acknowledging that group allocation had
not been at random. The third (interaction) term was
the one that would show any effect of the ethics ofﬁcer
intervention. The remaining terms were CTIMP status,
the percentage of interventional studies handled by the
REC and the REC workload (measured as studies
reviewed per meeting). The amount of administrative
support available to RECs was approximately the same,
so it was not included in the models.
As all of the explanatory variables were of importance
to the model, the forced-entry method was used in pref-
erence to stepwise selection. Results are expressed as
ORs with 95% CIs, together with the corresponding p
values.
Process evaluation of the applications to ethics officer
RECs
A process evaluation was conducted involving a survey of
applicants and an analysis of documents.
Survey. Applicants in the ethics ofﬁcer intervention
RECs were invited to complete an online survey feed-
back form (developed with input from a working group,
but not piloted) after their application had completed
review. Simple descriptive statistics were used to
summarise the ﬁndings, and responses to open-ended
questions were analysed thematically,19 facilitated by
NVivo10.
Documentary analysis. REC opinion letters and the
minutes of REC meetings relating to applications sub-
mitted in the baseline and intervention periods were
obtained from the HRA database. These, together with
the review forms completed by the ethics ofﬁcers for the
applications they handled, formed the ‘documentary
data’ for each application. Box 1 shows the sections
included in the ethics ofﬁcer review form.
The documentary data were coded using a framework
previously developed for categorising ‘issues’ in ethics
applications,19 20 24 deﬁned as any concern or query
raised during ethical review. For purposes of this analysis,
issues were organised into three categories: document
issues, ethical issues and study issues (box 2). Requests by
RECs for revisions to applications were coded as relating
to documents, procedures or further information.
Initial coding, facilitated by NVivo10 qualitative ana-
lysis software, was conducted by one researcher (CH). As
a check on consistency of coding, a random sample of
10 (9%) preintervention documentary data sets and 12
(12%) during-intervention documentary datasets were
also blind-coded by an independent coder (slightly
more during-intervention documents were blind-coded
to check consistency of the review form analysis). No
signiﬁcant discrepancies were noted between preinter-
vention and intervention coding. Some minor inconsist-
encies were noted in interpretation of the coding
framework; these were resolved by discussion.
RESULTS
The six ethics ofﬁcer RECs were collectively assigned
171 applications during the baseline period (May–
November 2012) and 192 applications during the inter-
vention period (May–November 2013). The 18 compara-
tor RECs were assigned 528 applications during the
baseline period and 551 during the intervention period.
Box 2 Categories of issues that might be identified in
applications for ethical approval
Document issues comprise any errors or inaccuracies with the
consent forms for participants, the participant information sheets
and similar documents relating to consent. Other document
issues include those relating to general practitioner letters, errors
in the electronic application form and associated documentation
(eg, investigator CVs and consent forms) and inconsistencies in
various parts of the application or absence of required documents
and wording.
Ethical issues include those related to the care and safety of
research participants, confidentiality and informed consent.
Study issues refer to those concerning the study design and
methods, justification of risk over the intended benefit, inclusion
and exclusion criteria, along with the appropriateness of recruit-
ment methods.
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Ethics ofﬁcer RECs considered a mean 4.99 applications
per meeting, while comparator RECs considered a mean
5.03 applications.
Exact matching by CTIMP review status was achieved,
but the percentage of interventional studies actually
reviewed could not be matched in all cases. One of the
ethics ofﬁcer RECs reviewed an unusually high percent-
age of interventional studies (62%) in the 2012 baseline
period, for which no match could be found. One of the
ethics ofﬁcer RECs and two of its comparators reviewed
no interventional studies from May to November 2012,
despite all being recognised for CTIMPs.
Proportion of favourable and provisional opinions
Favourable opinions: Ethics ofﬁcer RECs were slightly
more likely than comparator RECs to give favourable
opinions both before (33% vs 29%) and during (33% vs
26%) the intervention period (table 1). During the
intervention period, the percentage of favourable opi-
nions in the ethics ofﬁcer RECs remained the same,
while there was a small decrease in the comparator
RECs.
Provisional opinions: Ethics ofﬁcer RECs issued a
smaller percentage of provisional opinions, both before
and during the intervention, than did the comparator
RECs. In the ethics ofﬁcer RECs, the percentage of pro-
visional opinions stayed constant (57.3%) throughout
the study period. In the comparator group, provisional
opinions increased by 5% between 2012 and 2013.
Analysis showed that the variable dominating the
opinion outcome was whether or not the REC was recog-
nised to review CTIMPs (table 2). A CTIMP-recognised
REC was much less likely to issue a favourable opinion
and much more likely to issue a provisional opinion. A
modest but statistically signiﬁcant effect of year was also
found: more provisional and fewer favourable opinions
were issued in 2013 compared with 2012 (table 2).
However, the difference on this variable between ethics
ofﬁcer and comparator RECs was not statistically signiﬁ-
cant in either analysis. There were also no signiﬁcant
effects due to the baseline percentage of interventional
studies, nor of REC workload (studies per meeting).
A diagnostic measure for both analyses showed that
only 5% of the variation in opinion outcomes was
explainable using the variables analysed. The statistical
analyses thus fall far short of providing comprehensive
explanations of RECs’ decision-making.
Time taken to issue an opinion
Clock times were available for all applications, except
where ﬁnal opinions had not been issued at the time
data were retrieved (mid-December 2013). Times were
unavailable for 5 applications to ethics ofﬁcer RECs
(1.3% of the total) and 27 applications to comparator
RECs (2.5%). A minimal difference in clock times
between ethics ofﬁcer and comparator RECs was found.
A modest decrease in clock times from 2012 to 2013
occurred in the ethics ofﬁcer RECs (33.3 vs 32.0 days),
Table 1 Number and percentage of favourable and provisional opinions
May–November 2012
(baseline)
May–November 2013
(intervention period) Total
Favourable opinions
Ethics officer REC 56/171 (32.7) 63/192 (32.8) 119/363 (32.8)
Comparator REC 155/528 (29.4) 133/551 (26.2) 288/1079 (26.7)
Total 211/699 (30.1) 196/743 (26.4) 407/1442 (28.2)
Provisional opinions
Ethics officer REC 98/171 (57.3) 110/192 (57.3) 208/363 (57.3)
Comparator REC 334/528 (63.3) 378/551 (68.6) 712/1079 (66.0)
Total 432/699 (61.8) 478/743 (65.7) 920/1442 (63.8)
REC, research ethics committee.
Table 2 Results of logistic regressions of the probability of favourable and provisional opinions, treating each application as
the unit of analysis
Favourable opinion Provisional opinion
Variable OR 95% CI p Value OR 95% CI p Value
Year (2013 vs 2012) 0.73 0.56 to 0.96 0.025 1.32 1.02 to 1.71 0.034
EO vs comparator 0.80 0.35 to 1.84 0.59 1.10 0.50 to 2.42 0.82
Year×(EO vs comparator) 1.35 0.80 to 2.29 0.26 0.77 0.48 to 1.27 0.31
CTIMP status (no vs yes) 2.34 1.62 to 3.37 <0.001 0.38 0.26 to 0.54 <0.001
% interventional (per percentage point) 1.00 0.99 to 1.01 0.90 1.00 0.99 to 1.01 0.50
Workload (studies per meeting) 0.88 0.70 to 1.09 0.24 1.01 0.82 to 1.24 0.97
CTIMP, Clinical Trials of Investigational Medicinal Products; EO, ethics officer.
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while comparator RECs’ clock times increased slightly
(32.6 vs 32.9 days), but the effect was not statistically sig-
niﬁcant (p=0.22) (table 3).
Clock times showed no statistically signiﬁcant effect of
year, ethics ofﬁcer versus comparator, nor the inter-
action between them. The interaction term, had it been
signiﬁcant, would have indicated a reduction in clock
times in connection with the presence of ethics ofﬁcers.
Clock times varied signiﬁcantly by the REC’s CTIMP
status (32.9 vs 28.3 days, ﬂagged to review CTIMPs vs not
ﬂagged), by the percentage of interventional studies
reviewed, and by the REC’s workload. Busier RECs
(reviewing over ﬁve studies per meeting) took on
average two days longer to issue a ﬁnal opinion than
less busy RECs (33.7 vs 31.7 days (F 18.13, p=<0.001)
(table 4). As with the analysis of favourable and provi-
sional opinion rates, the analysis of variance (ANOVA)
explained only 5% of the variation in clock times
between applications.
Applicant survey
Responses to the survey were received from 51/171
(30%) of the applicants in the ethics ofﬁcer RECs.
Though all ethics ofﬁcers reported that they had circu-
lated the questionnaire, no responses were received from
applicants to two of the ethics ofﬁcer RECs. Generally,
respondents were satisﬁed with the ethics ofﬁcer interven-
tion; most agreed that the role (87%) and the advice
given (81%) were useful (table 5). Open-ended responses
suggested that applicants valued the support and reassur-
ance provided by the ethics ofﬁcer.
Helpful just to have a general conversation to explore
certain issues and options—the formal meeting can all
feel quite formal and potentially defensive rather than
supportive—Applicant 13
Potential improvements to the ethics ofﬁcer function
were also identiﬁed by applicants, including the need for
better communication between the REC and the ethics
ofﬁcer and a more well-deﬁned remit for the ethics
ofﬁcer. Twelve respondents suggested that the support
should be available before the application was submitted
for review.
The only other option I could imagine working would be
the option to submit your documents to the Ethics Ofﬁcer
prior to ethics submission. This way you would be submit-
ting a more robust application and time to a favourable
ethical opinion would be reduced.—Applicant 7
Documentary analysis
Ten applications were excluded from the documentary
analysis as a draft version of the ethics ofﬁcer review
form that had only been intended for use during famil-
iarisation, had been used. In one committee (REC4),
only three review forms were completed for the 30 appli-
cations submitted during the intervention period, so all
documents relating to this REC were excluded to ensure
comparability between RECs. Across the remaining ﬁve
RECs, 14 applicants opted out of the ethics ofﬁcer pilot
and their applications were not included in the docu-
mentary analysis.
Of the 171 applications to ethics ofﬁcer RECs in the
baseline period, 110 (64%) applications had full docu-
mentary data (opinion letters and minutes) (table 6).
Of 192 applications to ethics ofﬁcer RECs during the
intervention period, 100 (52%) had full documentary
data (opinion letters, minutes and review forms).
For the ethics ofﬁcer intervention to work, RECs
needed to convert some opinions that would otherwise
have been provisional opinions into favourable opinions,
on grounds that the revisions that had been identiﬁed
had been agreed with the applicants in advance.
However, review of the ethics ofﬁcer review forms sug-
gested that the ethics ofﬁcer and the principal applicant
did not in fact discuss the application in advance of the
REC meeting, as intended, in 31 of the 100 applications
(for which data were available) in the intervention
period. This happened for a variety of reasons: sometimes
the attempt at contact did not happen or failed, or the
applicants did not respond or were unavailable. The prac-
tical consequence was that in almost a third of cases the
intervention did not function as intended. A further
problem, implicated in four provisional opinions, was that
Table 4 Analysis of variance of clock times
Variable F ratio p Value
Year (2013 vs 2012) 0.33 0.57
EO vs comparator 0.39 0.53
Year×(EO vs comparator) 1.51 0.22
CTIMP status (no vs yes) 8.67 <0.001
% interventional (per percentage point) 20.75 <0.001
Workload (studies per meeting) 18.13 <0.001
CTIMP, Clinical Trials of Investigational Medicinal Products;
EO, ethics officer.
Table 3 Time taken to issue an opinion (clock times)
Number of applications, mean (SD)
days to final opinion
May–November 2012
(baseline)
May–November 2013
(intervention period) Total
Ethics officer REC 33.3 (11.9), n=171 32.0 (9.6), n=182 32.6 (10.8), n=353
Comparator REC 32.6 (13.2), n=531 32.9 (10.7), n=502 32.7 (12.0), n=1033
Total 32.8 (12.9), n=702 32.6 (10.4), n=684 32.7 (11.7), n=1386
REC, research ethics committee.
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the applicants did not address the advice given by the
ethics ofﬁcer in time. On at least one occasion, this was
because the applicants were only notiﬁed of the ethics
ofﬁcer review on the day of the full REC review.
Issues in applications and requests for action
The ethics ofﬁcers’ review form contained eight head-
ings including a heading relating to ‘issues’ (see box 1).
Review of completed forms found that not all forms con-
tained entries under each heading; ethics ofﬁcers some-
times left subsections blank.
Ethics ofﬁcers identiﬁed issues in most (87/100)
applications at pre-review, with a mean of 4.72 issues per
application. The issues they most frequently identiﬁed
were those relating to conﬁdentiality, design and
conduct of studies, and speciﬁc errors in participant in-
formation sheets and consent documentation (table 7).
On average, ethics ofﬁcers identiﬁed 3.2 issues in appli-
cations that went on to receive favourable opinions, com-
pared with 4.9 in those that received provisional
opinions and 6.9 in those that received unfavourable
opinions, suggesting some degree of alignment between
their review and the eventual opinion by the REC.
In four cases, the ethics ofﬁcer correctly identiﬁed in
advance that a provisional opinion was the likely
outcome; regardless of any proposed amendments
agreed with the applicants, they were of the view that
the application would need to be re-reviewed by the
REC. Ethics ofﬁcers also identiﬁed two cases in which
they did not foresee potentially preventable provisional
opinions. In one of these, the ethics ofﬁcer wrongly
advised the researcher that it was not necessary to
attend the REC meeting. In the other, the ethics ofﬁcer
did not anticipate issues that the REC saw as important.
Table 5 Applicants agreeing or strongly agreeing with survey statements
Survey statements
Number (%) ‘agreed’
or ‘strongly agreed’
I felt better prepared prior to attending the REC meeting 39/51 (76)
I felt more able to answer the questions from the REC 28/51 (55)
I needed to do further work following my conversation with the ethics officer 13/51 (25)
Any further work I did was a waste of time 4/51 (8)
The advice given by the ethics officer was useful 42/51 (82)
The advice given by the ethics officer was not useful 0/51 (0)
My involvement in the ethics officer pilot was tiresome 1/51 (2)
I’m glad I took part in the pilot 35/51 (69)
I believe the work conducted by the ethics officer was beneficial to me 39/51 (76)
If given the option again in the future, I would choose to take part in the pilot 39/51 (76)
In hindsight, I wish I had chosen to not participate in the pilot 0/51 (0)
I received a more favourable decision because of the help given by the ethics officer 14/51 (27)
REC, research ethics committee.
Table 6 Applications to ethics officer RECs with full documentary data available for process evaluation
Proportion of favourable
applications available
Proportion of
provisional
applications
Proportion of
unfavourable
applications
Proportion of all
applications included
Baseline period
REC1 10/11 19/19 0/0 29/29 (100%)
REC2 8/9 20/21 0/1 28/31 (90%)
REC3 0/17 5/7 0/5 5/29 (17%)
REC4 0/6 0/22 0/1 0/30 (0%)
REC5 8/9 11/14 5/5 24/28 (86%)
REC6 4/4 15/15 5/5 24/24 (100%)
Total for all RECs combined 30/56 (54%) 70/98 (71%) 10/17 (59%) 110/171 (64%)
Intervention period
REC1 2/6 15/27 2/4 19/37 (51%)
REC2 6/8 12/? 1/? 19/25 (76%)
REC3 5/19 5/? 3/? 13/37 (35%)
REC4 0/18 0/10 0/1 0/29 (0%)
REC5 8/11 16/20 1/1 25/32 (78%)
REC6 5/6 15/19 4/6 24/31 (77%)
Total for all RECs combined 26/68 (38%) 63/110 (57%) 11/19 (58%) 100/192 (52%)
REC, research ethics committee.
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For over a ﬁfth (22%) of all applications, ethics ofﬁ-
cers did not identify in advance any issues likely to cause
the applications to not receive a favourable opinion. Of
these applications, fewer than half (10) received a
favourable opinion. The remaining 12 applications
received a provisional opinion. One contained an
evident administrative error (incomplete application)
that potentially could have been identiﬁed by the ethics
ofﬁcer.
As might be expected, RECs were typically much more
detailed in their opinion letters than were ethics ofﬁ-
cers in their review forms, and accordingly the mean
number of issues with applications recorded by RECs
was higher than those recorded by ethics ofﬁcers; rates
of issue identiﬁcation are therefore not comparable
between RECs and ethics ofﬁcer. Issues were raised by
RECs for almost all applications (108/110 (98%)
before the intervention and 96/100 (96%) during the
intervention; table 8). There was little difference in the
number of issues RECs identiﬁed per application
during the baseline (12.5 issues per application) and
intervention (11.4 issues per application) periods
(table 8).
Though RECs and ethics ofﬁcers differed in the level
of detail and the number of issues they raised, they
could be compared in terms of the types of issues they
identiﬁed. RECs and ethics ofﬁcers identiﬁed the same
types of issues in 75/100 (75%) applications. Thus, for
example, the RECs and ethics ofﬁcers identiﬁed an issue
with the consent documentation in 17% of applications,
and also were consistent in identifying no issues with
consent in 58% applications. However, in 10 applications
in which the ethics ofﬁcer identiﬁed issues with consent
documentation, the REC did not identify any. Conversely,
the REC found fault with the consent form in 15 applica-
tions where the ethics ofﬁcer did not.
Ethics ofﬁcers recorded 296 issues that they documen-
ted as having discussed with the REC. For 250 of these,
they recorded whether the REC agreed or disagreed
with the speciﬁc point the ethics ofﬁcer was making.
The REC and ethics ofﬁcers generally were in agree-
ment in their views on ethical (72 out of 76 issues) and
study issues (40 out of 42 issues) and on issues relating
to participant documentation (123 of 132).
The number of requests RECs made of applicants for
revisions before and during the intervention period
showed little change. Most applicants—97/110 (88%) in
the baseline and 92/100 (92%) during the intervention
—were asked to make some revisions (table 9) and the
mean number of requests per application—6.4 before
and 6.7 during—were similar. RECs sometimes gave pro-
visional opinions even when it appeared that the revi-
sions required were minor and easily met the criteria for
a favourable with conditions opinion (eg, only documen-
tation issues were involved).
The patient information sheet needs rewriting in a less
Americanised format […] the standard NRES regulatory
clause should be included in the consent form.—REC6
(provisional opinion letter)
Table 7 Number and type of issues identified by ethics officers when they pre-reviewed applications. Source: ethics officer
review forms
Number of issues (number of applications affected*)
Favourable
opinion (n=26)
Provisional
opinion (n=63)
Unfavourable
opinion (n=11)
All
opinions (n=100)
Document issues
Consent documents, including patient
information sheets
7 (4) 34 (20) 3 (3) 44 (27)
Other documentation (eg, protocols, intervention
descriptions)
21 (10) 93 (44) 26 (11) 140 (65)
REC application 12 (8) 32 (23) 7 (6) 51 (37)
Subtotal 40 (12) 159 (52) 36 (11) 235 (75)
Ethical issues
Participant care 13 (6) 31 (24) 8 (5) 52 (35)
Confidentiality 11 (7) 46 (27) 8 (5) 65 (39)
Informed consent 3 (2) 16 (16) 5 (5) 24 (23)
Community issues 5 (3) 7 (7) 1 (1) 13 (12)
Subtotal 32 (13) 100 (43) 22 (8) 154 (64)
Study issues
Design and conduct 8 (7) 33 (25) 13 (7) 54 (39)
Recruitment 4 (4) 20 (14) 5 (3) 29 (21)
Subtotal 12 (10) 53 (32) 18 (8) 83 (50)
Total number of issues (number of applications
affected)
84 (18) 312 (58) 76 (11) 472 (87)
Mean issues per opinion category 3.2 5.0 6.9 4.7
*One application can generate more than one issue.
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DISCUSSION
This controlled study found that an ethics ofﬁcer inter-
vention did not increase the proportion of applications
to RECs that were approved ﬁrst time, nor did it reduce
the time to a ﬁnal opinion. Though the process evalu-
ation suggested that applicants generally valued the
ethics ofﬁcer service, that ethics ofﬁcers were successful
in identifying many issues with applications, and that
RECs and ethics ofﬁcers demonstrated good alignment
in their views on whether issues were justiﬁed, it also
provided some insights into the reasons for the null
result. A major challenge was that the intervention did
not function exactly as designed. For instance, ofﬁcers
did not reach applicants in advance of meetings in
almost a third of applications for which data were avail-
able, and they did not consistently anticipate issues in
applications that went on to get provisional opinions.
Perhaps more crucially, however, the behaviour of
RECs did not appear to change in response to the
ethics ofﬁcer intervention. They did not appear to
take reassurance from the ethics ofﬁcer process that
they would not need to re-review changes to applica-
tions. These ﬁndings are disappointing, in that they
indicate that an ethics ofﬁcer role as implemented
does not provide a straightforward ﬁx for some of the
current challenges in obtaining timely ethical approval
for studies. They also suggest potential targets for
improvement.
It is clear that a large number of avoidable errors con-
tinue to be made by applicants at the submission stage.
Reducing these might help in improving the rate of
favourable opinion at ﬁrst review, not least by reassuring
RECs that applicants have engaged seriously with the
process. It is possible that improvements to the applica-
tion process itself (eg, better clarity, more user-friendly
instructions) might help in reducing such errors, but
also likely to be important is more attention by appli-
cants themselves to the details of applications, including
consistency between different parts of applications,
grammatical correctness and compliance with applica-
tion instructions. Better training and education of appli-
cants may well be the key to this, and here organisations
in which applicants are based might take on a more
comprehensive role than they do at present. More thor-
ough checking of applications before submission, for
example by project sponsors, might be helpful, since
sponsors have a formal role in oversight of research. It is
unclear whether having ethics ofﬁcers act as proof-
readers would be appropriate, though they might be
able to advise applicants at an early stage if an applica-
tion does not appear to reach the required standard.
Also clear is that some applications involve more
complex ethical or procedural issues, where earlier sen-
sitisation by applicants to issues likely to be of concern
to RECs might be helpful. Here, upfront discussion with
an ethics ofﬁcer might be of value before an application
is submitted.
Better preparation by applicants might go some way
towards reducing delays and improving the experiences
of applicants at research ethics review. However, a more
comprehensive solution is likely to be elusive without
changes in the norms and behaviours of RECs them-
selves. The evidence in this study and others24–26 sug-
gests that RECs ﬁnd it difﬁcult to resist identifying issues
with applications (virtually none escaped without an
issue either before or during the intervention), and that
Table 8 Issues with applications identified by RECs before and during the ethics officer intervention. Source: REC meeting
minutes and opinion letters
Baseline (n=110 applications) Intervention period (n=100 applications)
Type of issue
Number
of issues
Number (% of all)
applications with
an issue
Mean number
of issues per
application
Number
of issues
Number
(% of all)
applications
Mean number
of issues per
application
Document issues
Consent documents 45 27 (25) 0.4 46 32 (32) 0.5
Other documentation 298 85 (77) 2.7 268 85 (85) 2.7
REC application 121 57 (52) 1.1 81 43 (43) 0.8
Subtotal 464 93 (85) 4.2 395 88 (88) 3.9
Ethical issues
Participant care 249 89 (81) 2.3 207 75 (75) 0.7
Confidentiality 147 68 (62) 1.3 132 57 (57) 0.6
Informed consent 30 23 (21) 0.3 31 24 (24) 0.2
Community issues 10 10 (9) 0.1 20 18 (18) 0.2
Subtotal 436 101 (92) 4.0 390 84 (84) 0.8
Study issues
Design and conduct 299 93 (85) 2.7 225 78 (78) 0.8
Recruitment 179 82 (75) 1.6 131 65 (65) 0.6
Subtotal 478 104 (95) 4.3 356 88 (88) 0.9
Total issues 1378 108 (98) 12.5 1141 96 (96) 11.4
REC, research ethics committee.
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they tend to default to provisional opinions even when
an approval with conditions would be a reasonable
option. Previous analyses have suggested that this may
be because RECs see the production of a list of issues as
a display of their own diligence and as serving the inter-
ests of accountability.27 28 Appropriately targeted educa-
tional interventions may be helpful in addressing these
problems, as may reinforcement of new norms through
accountability mechanisms—for example, RECs might
be asked to provide additional explanation or rationale
for a random sample of decisions each year, perhaps
through a reciprocal peer review arrangement with
other RECs. Qualitative work may be especially useful in
understanding the impact of such arrangements on
decision-making.9 10
This study has a number of limitations. RECs had
volunteered for the task, and knew that they were being
studied; this may have inﬂuenced their behaviour and
decision-making. The ethics ofﬁcers themselves, as
experienced chairs of RECs, may not have been fully
representative of those likely to occupy such roles in real
life, nor is it clear that the ethics ofﬁcers fully or consist-
ently complied with the instructions they were given—
raising questions about intervention ﬁdelity. It is possible
that applications for which data were not available were
different in some way. The statistical analyses explained
only small percentages of the variation in outcomes, pos-
sibly because variables important for the context were
not available. Clock times were missing for a small
number of applications. It was not possible to choose
comparator RECs that matched the ethics ofﬁcer RECs
entirely as had been planned. Interviews with applicants,
ethics ofﬁcers and REC members, chairs and staff would
have been useful, as would ethnography of REC meet-
ings, but were not possible for budgetary reasons. The
process evaluation was challenged by missing data: only
just over half of applications in the intervention period,
and just under two-thirds in the preintervention period,
had full documentary data available.
CONCLUSIONS
Addressing challenges in the governance of research is
unlikely to be straightforward. This controlled study sug-
gests that an ethics ofﬁcer intervention, at least as
designed and implemented in this project, does not
confer advantages in terms of increasing rates of
approvals at ﬁrst review of applications by a research
ethics committee nor in decreasing time to committee
decision. Improvements are likely to require changes in
the culture and behaviours of applicants and research
ethics committees. Other forms of the ethics ofﬁcer role
—for example one that provides more upfront support
prior to formal submission—might also be valuable and
would beneﬁt from evaluation. Future studies of this
kind of intervention might usefully standardise the train-
ing, eligibility thresholds and precise roles of those
serving as ethics ofﬁcers, and, subject to systems amend-
ments being made to enable it, allow the ethics ofﬁcers
and consenting applicants to amend their applications
before formal ethics review.
Table 9 RECs’ requests for revisions by applicants before and during the intervention. Source: REC meeting minutes and
opinion letters
Baseline (n=110 applications) Intervention (n=100 applications)
Number of revisions
requested
Number (% of all)
applications
Number of revisions
requested
Number (% of all)
applications
Documentation revisions
Consent documentation 84 44 (40) 74 46 (46)
Other documentation 373 89 (81) 310 86 (86)
Subtotal 457 93 (85) 384 89 (89)
Procedural revisions
Consent procedures 8 7 (6) 17 17 (17)
Data storage procedures 1 1 (1) 0 0 (0)
Recruitment procedures 7 6 (5) 0 0 (0)
Study design 6 6 (5) 7 7 (7)
Study protocol 15 12 (11) 14 12 (12)
Subtotal 37 24 (22) 38 29 (29)
Further information to be submitted
Study design 69 38 (35) 58 28 (28)
Further documentation 19 17 (15) 9 8 (8)
Ethical practice 71 50 (45) 63 33 (33)
Improved application 7 6 (5) 13 9 (9)
Protocol and procedures 1 1 (1) 47 33 (33)
Researcher credentials 33 27 (25) 7 7 (7)
Other 12 12 (11) 0 0 (0)
Subtotal 212 77 (70) 197 58 (58)
Total 706 97 (88) 619 92 (92)
REC, research ethics committee.
Dixon-Woods M, et al. BMJ Open 2016;6:e011973. doi:10.1136/bmjopen-2016-011973 11
Open Access
group.bmj.com on September 7, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
Author affiliations
1Institute of Public Health, Forvie Site, University of Cambridge School of
Clinical Medicine, Cambridge, UK
2R&D, Gloucestershire Hospitals NHS Foundation Trust, Gloucester, UK
3North Bristol NHS Trust, Southmead Hospital, Bristol, UK
4Centre for Clinical Brain Sciences, School of Clinical Sciences, College of
Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, UK
5Health Research Authority, London, UK
6BMJ, BMA House, London, UK
Twitter Follow Mary DixonWoods at @MaryDixonWoods
Acknowledgements The authors thank the ethics officers and research ethics
committees who participated in this project. The authors thank Leonard Key and
Janet Wisely of the Health Research Authority for their support for the project.
Contributors MD-W, SS and RA-SS helped design the study in collaboration
with ST. CF contributed to study design and selection of comparators, and
conducted all of the statistical analysis. MDW and CH undertook the data
analysis for the process evaluation. ST produced all guidance,
communications, questionnaires, forms and other documentation in support
of this study. All authors contributed to the preparation of the manuscript and
approved the final version. Non-author contributors: Janet Wisely came up
with the idea for the study and provided strategic direction throughout;
Leonard Key supported the study through the collation and analysis of
information and the matching of RECs; Liz Shaw project managed the
process evaluation and helped in resolving queries; Emma Angell and
Veronica Heney provided support in manuscript preparation.
Funding The ethics officer pilot and the controlled evaluation was funded by
the HRA. The process evaluation was conducted and funded separately by
MD-W’s Wellcome Trust Investigator Award WT097899 with no HRA
oversight or involvement beyond facilitating access to the database. MD-W’s
contribution to this paper was also supported by University of Leicester study
leave at the Dartmouth Institute for Health Policy and Clinical Practice. RA-SS
was funded by a Medical Research Council senior clinical fellowship.
Competing interests MD-W’s employers received honoraria for her
attendance at meetings to discuss the study. CF is an REC Chair, but not of
any of the ethics officer or comparator RECs. ST is the Head of Corporate
Governance for the Health Research Authority. SS is employed by the BMJ
Publishing Group (which publishes BMJ Open) but is not involved in the
decision-making for this journal.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement No additional data are available.
Open Access This is an Open Access article distributed in accordance with
the terms of the Creative Commons Attribution (CC BY 4.0) license, which
permits others to distribute, remix, adapt and build upon this work, for
commercial use, provided the original work is properly cited. See: http://
creativecommons.org/licenses/by/4.0/
REFERENCES
1. Liddell A, Ayling M, Reid G. Innovation, health and wealth
accelerating adoption and diffusion in the NHS. Department of
Health, 2011.
2. UK Department for Business, Innovation and Skills. Strategy for UK
life sciences. One Year On. London, UK: Office for Life Sciences,
Department for Business, Innovation and Skills, 2012.
3. Commons Select Committee Science and Technology. The Impact
of Spending Cuts on Science and Scientific Research Sixth Report
of Session 2009–10. The Stationery Office, 2010.
4. HM Treasury and Department for Business Innovation and Skills.
The Plan for Growth. HM Treasury/DBIS, 2011.
5. Ijsselmuiden C, Marais D, Becerra-Posada F, et al. Africa’s
neglected area of human resources for health research-the way
forward. S Afr Med J 2012;102:228–33.
6. Department of Health. Research governance framework for health
and social care. 2nd ed. Department of Health, 2005.
7. Dixon-Woods M, Ashcroft RE. Regulation and the social licence for
medical research. Med Health Care Philos 2008;11:381–91.
8. Al-Shahi Salman R, Beller E, Kagan J, et al. Increasing value and
reducing waste in biomedical research regulation and management.
Lancet 2014;383:176–85.
9. Stark L. Behind closed doors: IRBs and the making of ethical
research. University of Chicago Press, 2011.
10. Klitzman R. The ethics police? The struggle to make human
research safe. Oxford University Press, 2015.
11. Thompson AG, France EF. One stop or full stop? The continuing
challenges for researchers despite the new streamlined NHS
research governance process. BMC Health Serv Res
2010;10:124.
12. Hoonaard W. The New Brunswick Declaration on Research Ethics,
Integrity, and Governance. Journal of Clinical Research & Bioethics
2016;7:268.
13. Pollock K. Procedure versus process: ethical paradigms and the
conduct of qualitative research. BMC Med Ethics 2012;13:25.
14. Nicholls SG, Hayes TP, Brehaut et al A Scoping Review of Empirical
Research Relating to Quality and Effectiveness of Research Ethics
Review. PLoS ONE 2015;10:e0133639.
15. Whitney SN, Alcser K, Schneider CE, et al. Principal investigator
views of the IRB system. Int J Med Sci 2008;5:68–72.
16. Abbott L, Grady C. A systematic review of the empirical literature
evaluating IRBs: what we know and what we still need to learn.
J Empir Res Hum Res Ethics 2011;6:3–19.
17. Snooks H, Hutchings H, Seagrove A, et al. Bureaucracy stifles
medical research in Britain: a tale of three trials. BMC Med Res
Methodol 2012;12:122.
18. Health Research Authority. Health Research Authority Annual
Report and Accounts. 2014.
19. O’Reilly M, Dixon‐Woods M, Angell E, et al. Doing accountability: a
discourse analysis of research ethics committee letters. Sociol
Health Illness 2009;31:246–61.
20. Angell E, Dixon-Woods M. Do research ethics committees identify
process errors in applications for ethical approval? J Med Ethics
2009;35:130–2.
21. Cleaton-Jones P. Process error rates in general research
applications to the Human Research Ethics Committee (Medical) at
the University of the Witwatersrand: a secondary data analysis. S Afr
J Bioeth Law 2010;3:20–4.
22. Tsoka-Gwegweni JM, Wassenaar DR. Using the Emanuel et al.
framework to assess ethical issues raised by a biomedical research
ethics committee in South Africa. J Empir Res Hum Res Ethics
2014;9:36–45.
23. Davidoff F, Dixon-Woods M, Leviton L, et al. Demystifying
theory and its use in improvement. BMJ Qual Saf 2015;24:228–38.
24. Angell EL, Bryman A, Ashcroft RE, et al. An analysis of decision
letters by research ethics committees: the ethics/scientific quality
boundary examined. Qual Saf Health Care 2008;17:131–6.
25. Angell E, Jackson CJ, Ashcroft RE, et al. Is ‘inconsistency’ in
research ethics committee decision-making really a problem?
An empirical investigation and reflection. Clin Ethics 2007;2:
92–9.
26. Angell E, Sutton AJ, Windridge K, et al. Consistency in decision
making by research ethics committees: a controlled comparison.
J Med Ethics 2006;32:662–4.
27. Dixon-Woods M, Angell E, Ashcroft RE, et al. Written work: the
social functions of Research Ethics Committee letters. Soc Sci Med
2007;65:792–802.
28. Armstrong N, Dixon-Woods M, Thomas A, et al. Do informed
consent documents for cancer trials do what they should? A study
of manifest and latent functions. Sociol Health Illn
2012;34:1230–45.
12 Dixon-Woods M, et al. BMJ Open 2016;6:e011973. doi:10.1136/bmjopen-2016-011973
Open Access
group.bmj.com on September 7, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
evaluation of an improvement project
research ethics approval? A mixed-method 
Can an ethics officer role reduce delays in
Salman, Stephen Tebbutt and Sara Schroter
Mary Dixon-Woods, Chris Foy, Charlotte Hayden, Rustam Al-Shahi
doi: 10.1136/bmjopen-2016-011973
2016 6: BMJ Open 
 http://bmjopen.bmj.com/content/6/8/e011973
Updated information and services can be found at: 
These include:
References
 #BIBLhttp://bmjopen.bmj.com/content/6/8/e011973
This article cites 20 articles, 7 of which you can access for free at: 
Open Access
http://creativecommons.org/licenses/by/4.0/
use, provided the original work is properly cited. See: 
others to distribute, remix, adapt and build upon this work, for commercial
the Creative Commons Attribution (CC BY 4.0) license, which permits 
This is an Open Access article distributed in accordance with the terms of
service
Email alerting
box at the top right corner of the online article. 
Receive free email alerts when new articles cite this article. Sign up in the
Collections
Topic Articles on similar topics can be found in the following collections 
 (1091)Health services research
 (70)Ethics
Notes
http://group.bmj.com/group/rights-licensing/permissions
To request permissions go to:
http://journals.bmj.com/cgi/reprintform
To order reprints go to:
http://group.bmj.com/subscribe/
To subscribe to BMJ go to:
group.bmj.com on September 7, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
